Clinical Trial Details
| Trial ID: | L2903 |
| Source ID: | NCT01398592 |
| Associated Drug: | Vildagliptin |
| Title: | Vildagliptin Versus Sitagliptin - Differences in Fasting Plasma Glucose Lowering Efficacy |
| Acronym: | FPG-VISIT |
| Status: | COMPLETED |
| Study Results: | NO |
| Results: | |
| Conditions: | Diabetes Mellitus Type 2 |
| Interventions: | DRUG: Vildagliptin|DRUG: Sitagliptin |
| Outcome Measures: | Primary: demonstrate that the FPG after 14 days of treatment with Vildagliptin is superior to the FPG after 14 days of treatment with Sitagliptin, Fasting Plasma Glucose measured on day 14., 14 days | Secondary: To assess the difference in FPG between vildagliptin and sitagliptin in patients with type 2 diabetes mellitus on concomitant treatment with metformin, Fasting Plasma Glucose on day 14 analyzed descriptively., 14 days |
| Sponsor/Collaborators: | Sponsor: Novartis Pharmaceuticals |
| Gender: | ALL |
| Age: | ADULT, OLDER_ADULT |
| Phases: | PHASE4 |
| Enrollment: | 187 |
| Study Type: | INTERVENTIONAL |
| Study Designs: | Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT |
| Start Date: | 2011-06 |
| Completion Date: | 2012-06 |
| Results First Posted: | |
| Last Update Posted: | 2013-02-12 |
| Locations: | Novartis Investigative Site, Bad Oeynhausen, 32549, Germany|Novartis Investigative Site, Berlin, 12347, Germany|Novartis Investigative Site, Berlin, 13597, Germany|Novartis Investigative Site, Berlin, 14089, Germany|Novartis Investigative Site, Celle, 29221, Germany|Novartis Investigative Site, Hannover, 30165, Germany|Novartis Investigative Site, Hannover, 30167, Germany|Novartis Investigative Site, Kassel, 34117, Germany|Novartis Investigative Site, Kirchhain, 35274, Germany|Novartis Investigative Site, Lehrte, 31275, Germany|Novartis Investigative Site, Mülheim, 45468, Germany|Novartis Investigative Site, Oberhausen, 46049, Germany|Novartis Investigative Site, Osnabrück, 49080, Germany|Novartis Investigative Site, Potsdam, 14469, Germany|Novartis Investigative Site, Stuttgart, 70378, Germany |
| URL: | https://clinicaltrials.gov/show/NCT01398592 |
